N. Wang et al.
DyesandPigments163(2019)425–432
give pure product N, N′-diaryl-dihydrodibenzo[a, c]phenazines (DPAC)
(Yield:160 mg, 27%). 1H NMR (300 MHz, CDCl3) δ: 8.76 (d, J = 9 Hz,
2H), 8.16 (d, J = 6 Hz, 2H), 7.76 (s, 2H), 7.65 (d, J = 6 Hz, 2H), 7.56
(d, J = 6 Hz, 2H), 7.35 (s, 2H), 7.01 (s, 8H), 6.80 (s, 2H).
2.2.6. Synthesis
of
the
(dibenzo[a,c]phenazine-9,14-diylbis(4,1-
phenylene))bis(methylene)bis((4-
(2-oxohexahydro-1H-thieno[3,4-d]
imidazol-4-yl)butyl)carbamate) (DPAC-DB)
DPAC-OH (250 mg, 0.5 mmol), biotin (489 mg, 2.0 mmol), DPPA
(413 mg, 2.0 mmol), and Et3N (141 mg, 2.0 mmol) were dissolved with
anhydrous CH3CN (10 mL), and the solution was continuously stirred
overnight in nitrogen at 55 °C. The reaction mixture was cooled before
vacuum dry. The resulting residue was reconstituted in DCM (50 mL)
and sequentially washed with 5% aq citric acid (2 × 50 mL), water
(50 mL), saturated aq NaHCO3 (50 mL) and brine (50 mL). The organic
phase was isolated and then dried with Na2SO4. Purification by flash
chromatography (eluent: 10% CH3OH in DCM) gave DPAC-DB as a
white solid (Yield: 200 mg, 41%). 1H NMR (500 MHz, DMSO‑d6) δ: 8.95
(d, J = 5 Hz, 2H), 7.92-7.90 (m, 4H), 7.72 (t, J = 15 Hz, 2H), 7.62 (t,
J = 15 Hz, 2H), 7.44-7.42 (m, 2H), 7.14 (t, J = 10 Hz, 2H), 7.09 (d,
J = 10 Hz, 4H), 7.00 (d, J = 10 Hz, 4H), 6.43 (s, 2H), 6.38 (s, 2H), 4.80
(s, 4H), 4.26-4.25 (m, 2H), 4.09-4.07 (m, 2H), 3.06-3.02 (m, 2H), 2.93-
2.92 (m, 4H), 2.78-2.76 (m, 2H), 2.56 (d, J = 10 Hz, 2H), 1.59-1.54 (m,
2H), 1.45-1.41 (m, 6H), 1.36-1.33 (m, 4H); 13C NMR (125 MHz,
DMSO‑d6) δ: 162.73, 156.10, 143.67, 136.86, 129.55, 129.29, 128.19,
127.03, 125.81, 123.76, 116.26, 64.89, 60.91, 59.20, 55.48, 29.20,
24.50, 22.10. HRMS (m/z): calcd [M+Na]+ for C54H54N8O6S2Na:
999.3764; found, 999.3721.
2.2.3. Synthesis
of
the
4,4'-(dibenzo[a,c]phenazine-9,14-diyl)
dibenzaldehyde (DPAC-CHO)
Phosphorus oxychloride (3.5 g, 22.8 mmol) was injected into N, N′-
dimethylformamide (5.0 mL) under a nitrogen atmosphere at 0 °C, and
the mixture was vigorously stirred for 1 h to obtain the Vilsmeier re-
agent. The solution of DPAC (1.0 g, 2.3 mmol) in N, N′-di-
methylformamide (10 mL) was then added by dropwise. The mixture
was heated to 85 °C and stirred for 12 h. After cooling to room tem-
perature, the reaction mixture was poured into ice water, followed by
the adjustment of pH to neutral. The deep yellow precipitate was then
filtered and purified by column chromatography eluting with 20%
petroleum ether in dichloromethane. A light yellow product 4, 4'-(di-
benzo[a,c]phenazine-9, 14-diyl)dibenzaldehyde (DPAC-CHO) was ob-
tained (Yield: 0.9 g, 80%). 1H NMR (300 MHz, CDCl3) δ: 9.69 (s, 2H),
8.81 (d, J = 6 Hz, 2H), 8.07 (d, J = 9.0 Hz, 2H), 7.85 (dd, J1 = 3 Hz,
J2 = 6 Hz, 2H), 7.76 (t, J = 15 Hz, 2H), 7.63 (t, J = 15 Hz, 2H), 7.54 (d,
J = 9 Hz, 4H), 7.49 (dd, J1 = 3 Hz, J2 = 6 Hz, 2H), 7.01 (d, J = 9 Hz,
4H). 13C NMR (125 MHz, DMSO‑d6) δ: 190.72, 150.78, 142.89, 137.06,
131.04, 129.70, 129.18, 127.91, 127.72, 127.69, 127.56, 126.77,
123.95, 123.72, 114.72. HRMS (m/z): [M+H]+ calcd for C34H23N2O2,
491.1754; found, 491.1754.
2.3. Preparation of probes and analytes
Concentrated liquor of probe (1.0 mM) was prepared in DMSO. Test
solution of probe (2 μM) in DMSO/H2O was obtained by diluting con-
centrated liquor. All solutions was stored in 1.5 mL centrifuge tube, and
then shaken well and incubated at room temperature. Avidin stock
solution was prepared by diluting commercial avidin solid with purified
2.2.4. Synthesis
of
the
(dibenzo[a,c]phenazine-9,14-diylbis(4,1-
phenylene))dimethanol (DPAC-OH)
DPAC-CHO (1.0 g, 2.0 mmol) was dissolved in 30 mL methanol, and
sodium borohydride (0.8 g, 21 mmol) was then added in an ice bath.
The mixture was stirred overnight at room temperature. The reaction
mixture was poured into ice water, followed by the filtration of beige
precipitate to give the DPAC-OH (Yield: 0.9 g, 89%). 1H NMR
(300 MHz, DMSO‑d6) δ: 8.92 (d, J = 6.0 Hz, 2H), 7.96 (d, J = 6.0 Hz,
2H), 7.88 (s, 2H), 7.69 (s, 2H), 7.59 (s, 2H), 7.40 (s, 2H), 7.03 (m, 8H),
4.95 (s, 2H), 4.30 (d, J = 3.0 Hz, 4H). 13C NMR (125 MHz, DMSO‑d6) δ:
145.95, 143.88, 136.76, 135.57, 129.41, 128.82, 128.24, 128.12,
127.37, 127.12, 126.71, 125.46, 123.74, 123.55, 116.91, 62.36. HRMS
(m/z): [M+H]+ calcd for C34H27N2O2, 495.2067; found, 495.2063.
water with the concentration of 10 μg μL−1
.
2.4. The spectroscopic testing procedures
The equilibrium and kinetics of the reaction between avidin and
biotin were investigated at different feed avidin concentration with
DPAC-SB/DPAC-DB (Final concentration: 2 μM) and the experiments
were carried out at 298 K and incubation time of 1 min. For the effect of
avidin concentration on avidin-biotin interaction, 1.5 mL centrifuge
tube containing a uniform DPAC-SB/DPAC-DB concentration (2 μM)
and a variable avidin concentration were incubated at 298 K for 1 min,
which was then measured at 355 nm excitation and 450 nm emission
wavelength (10 nm slit for standard experiments). The effect of pH on
avidin-biotin interaction was investigated at different pH values (from
4.0 to 8.0). The fluorescence emission spectrum of the probe DPAC-DB
(2 μM) and the DPAC-DB (2 μM) with avidin (1.03 μg μL−1) were
measured after incubating for 1 min in various pH solutions In all the
measurements, the effect of dilution was corrected being repeated each
measurements by triplicate and the mean and standard deviation were
calculated.
2.2.5. Synthesis of the 4-(14-(4-(hydroxymethyl)phenyl)dibenzo[a,c]
phenazin-9(14H)- yl)benzyl(4-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-
4-yl)butyl)carbamate (DPAC-SB)
DPAC-OH (250 mg, 0.5 mmol), biotin (244 mg, 1.0 mmol), DPPA
(206 mg, 1.0 mmol), and Et3N (71 mg, 1.0 mmol) were dissolved with
anhydrous CH3CN (10 mL), and the solution was continuously stirred
overnight in nitrogen at 55 °C. The reaction mixture was cooled before
vacuum dry. The resulting residue was reconstituted in DCM (50 mL)
and sequentially washed with 5% aq citric acid (2 × 50 mL), water
(50 mL), saturated aq NaHCO3 (50 mL) and brine (50 mL). The organic
phase was isolated and then dried with Na2SO4. Purification by flash
chromatography (eluent: 5% CH3OH in DCM) gave DPAC-SB as a white
solid (Yield: 140 mg, 38%). 1H NMR (500 MHz, DMSO‑d6) δ: 8.94 (d,
J = 10 Hz, 2H), 7.94-7.90 (m, 4H), 7.72-7.68 (m, 2H), 7.64-7.57 (m,
2H), 7.42-7.40 (m, 2H), 7.13 (t, J = 15 Hz, 1H), 7.07-6.98 (m, 8H),
6.42 (s, 1H), 6.36 (s, 1H), 4.81 (s, 2H), 4.31 (s, 2H), 4.28-4.25 (m, 1H),
4.10-4.06 (m, 1H), 3.05-3.03 (m, 1H), 2.95-2.90 (m, 2H), 2.79-2.75 (m,
1H), 2.59-2.53 (m, 1H), 1.60-1.54 (m, 1H), 1.45-1.41 (m, 3H), 1.39-
1.34 (m, 2H); 13C NMR (125 MHz, DMSO‑d6) δ: 162.74, 156.11,
146.74, 145.75, 137.12, 135.68, 129.28, 128.21, 127.49, 126.91,
123.89, 123.74, 116.24, 64.89, 62.40, 60.90, 59.19, 55.49, 29.83,
27.96, 25.77. HRMS (m/z): calcd [M+Na]+ for C44H40N5O4SNa:
758.2801; found, 758.2792.
2.5. The method for determining the limit of detection (DPAC-DB)
First the calibration curve was obtained from the plot of fluores-
cence intensity ratio (I450/I600), as a function of the avidin concentra-
tion. The regression curve equation was then obtained for the lower
concentration part.
The detection limit = 3 × S.D. / k
Where k is the slope of the curve equation, and S.D. represents the
standard deviation for the probe DPAC-DB solution's fluorescence in-
tensity ratio (I450/I600) in the absence of avidin [38].
I
450/I600 = 0.65442 + 14.1773[avidin] (R2 = 0.9928)
427